Cargando…

Little enhancement of meal‐induced glucagon‐like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls

Although glucose‐dependent insulinotropic polypeptide (GIP) levels have been characterized previously, GLP‐1 levels in Asians remain unclear. Here, we investigate total and intact levels of GLP‐1, as well as GIP during oral glucose and meal tolerance tests (OGTT and MTT) in Japanese patients with or...

Descripción completa

Detalles Bibliográficos
Autores principales: Yabe, Daisuke, Kuroe, Akira, Lee, Soushou, Watanabe, Koin, Hyo, Takanori, Hishizawa, Masahiro, Kurose, Takeshi, Deacon, Carolyn F, Holst, Jens J, Hirano, Tsutomu, Inagaki, Nobuya, Seino, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020678/
https://www.ncbi.nlm.nih.gov/pubmed/24843409
http://dx.doi.org/10.1111/j.2040-1124.2010.00010.x
_version_ 1782316102483705856
author Yabe, Daisuke
Kuroe, Akira
Lee, Soushou
Watanabe, Koin
Hyo, Takanori
Hishizawa, Masahiro
Kurose, Takeshi
Deacon, Carolyn F
Holst, Jens J
Hirano, Tsutomu
Inagaki, Nobuya
Seino, Yutaka
author_facet Yabe, Daisuke
Kuroe, Akira
Lee, Soushou
Watanabe, Koin
Hyo, Takanori
Hishizawa, Masahiro
Kurose, Takeshi
Deacon, Carolyn F
Holst, Jens J
Hirano, Tsutomu
Inagaki, Nobuya
Seino, Yutaka
author_sort Yabe, Daisuke
collection PubMed
description Although glucose‐dependent insulinotropic polypeptide (GIP) levels have been characterized previously, GLP‐1 levels in Asians remain unclear. Here, we investigate total and intact levels of GLP‐1, as well as GIP during oral glucose and meal tolerance tests (OGTT and MTT) in Japanese patients with or without type 2 diabetes (T2DM). Seventeen Japanese healthy controls and 18 age‐matched and untreated patients with T2DM of short duration participated in the present study. Fasting levels of total GPL‐1 were similar between the two groups (approximately 15 pM), and intact GLP‐1 levels were considerably low in both groups (less than 1 pM). In both groups, total GLP‐1 reached a peak 30 min after glucose ingestion (30–40 pM), whereas intact GLP‐1 levels remained low with no significant peak. In MTT, total and intact GLP‐1 showed no obvious peak. The current data indicate that intact GLP‐1 levels are considerably low in the Japanese and that meal‐induced enhancement of GLP‐1 secretion is negligible in the Japanese. (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2010.00010.x, 2010)
format Online
Article
Text
id pubmed-4020678
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-40206782014-05-19 Little enhancement of meal‐induced glucagon‐like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls Yabe, Daisuke Kuroe, Akira Lee, Soushou Watanabe, Koin Hyo, Takanori Hishizawa, Masahiro Kurose, Takeshi Deacon, Carolyn F Holst, Jens J Hirano, Tsutomu Inagaki, Nobuya Seino, Yutaka J Diabetes Investig Articles Although glucose‐dependent insulinotropic polypeptide (GIP) levels have been characterized previously, GLP‐1 levels in Asians remain unclear. Here, we investigate total and intact levels of GLP‐1, as well as GIP during oral glucose and meal tolerance tests (OGTT and MTT) in Japanese patients with or without type 2 diabetes (T2DM). Seventeen Japanese healthy controls and 18 age‐matched and untreated patients with T2DM of short duration participated in the present study. Fasting levels of total GPL‐1 were similar between the two groups (approximately 15 pM), and intact GLP‐1 levels were considerably low in both groups (less than 1 pM). In both groups, total GLP‐1 reached a peak 30 min after glucose ingestion (30–40 pM), whereas intact GLP‐1 levels remained low with no significant peak. In MTT, total and intact GLP‐1 showed no obvious peak. The current data indicate that intact GLP‐1 levels are considerably low in the Japanese and that meal‐induced enhancement of GLP‐1 secretion is negligible in the Japanese. (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2010.00010.x, 2010) Blackwell Publishing Ltd 2010-03-03 2010-04-22 /pmc/articles/PMC4020678/ /pubmed/24843409 http://dx.doi.org/10.1111/j.2040-1124.2010.00010.x Text en © 2010 Asian Association for the Study of Diabetes and Blackwell Publishing Asia Pty Ltd
spellingShingle Articles
Yabe, Daisuke
Kuroe, Akira
Lee, Soushou
Watanabe, Koin
Hyo, Takanori
Hishizawa, Masahiro
Kurose, Takeshi
Deacon, Carolyn F
Holst, Jens J
Hirano, Tsutomu
Inagaki, Nobuya
Seino, Yutaka
Little enhancement of meal‐induced glucagon‐like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls
title Little enhancement of meal‐induced glucagon‐like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls
title_full Little enhancement of meal‐induced glucagon‐like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls
title_fullStr Little enhancement of meal‐induced glucagon‐like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls
title_full_unstemmed Little enhancement of meal‐induced glucagon‐like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls
title_short Little enhancement of meal‐induced glucagon‐like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls
title_sort little enhancement of meal‐induced glucagon‐like peptide 1 secretion in japanese: comparison of type 2 diabetes patients and healthy controls
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020678/
https://www.ncbi.nlm.nih.gov/pubmed/24843409
http://dx.doi.org/10.1111/j.2040-1124.2010.00010.x
work_keys_str_mv AT yabedaisuke littleenhancementofmealinducedglucagonlikepeptide1secretioninjapanesecomparisonoftype2diabetespatientsandhealthycontrols
AT kuroeakira littleenhancementofmealinducedglucagonlikepeptide1secretioninjapanesecomparisonoftype2diabetespatientsandhealthycontrols
AT leesoushou littleenhancementofmealinducedglucagonlikepeptide1secretioninjapanesecomparisonoftype2diabetespatientsandhealthycontrols
AT watanabekoin littleenhancementofmealinducedglucagonlikepeptide1secretioninjapanesecomparisonoftype2diabetespatientsandhealthycontrols
AT hyotakanori littleenhancementofmealinducedglucagonlikepeptide1secretioninjapanesecomparisonoftype2diabetespatientsandhealthycontrols
AT hishizawamasahiro littleenhancementofmealinducedglucagonlikepeptide1secretioninjapanesecomparisonoftype2diabetespatientsandhealthycontrols
AT kurosetakeshi littleenhancementofmealinducedglucagonlikepeptide1secretioninjapanesecomparisonoftype2diabetespatientsandhealthycontrols
AT deaconcarolynf littleenhancementofmealinducedglucagonlikepeptide1secretioninjapanesecomparisonoftype2diabetespatientsandhealthycontrols
AT holstjensj littleenhancementofmealinducedglucagonlikepeptide1secretioninjapanesecomparisonoftype2diabetespatientsandhealthycontrols
AT hiranotsutomu littleenhancementofmealinducedglucagonlikepeptide1secretioninjapanesecomparisonoftype2diabetespatientsandhealthycontrols
AT inagakinobuya littleenhancementofmealinducedglucagonlikepeptide1secretioninjapanesecomparisonoftype2diabetespatientsandhealthycontrols
AT seinoyutaka littleenhancementofmealinducedglucagonlikepeptide1secretioninjapanesecomparisonoftype2diabetespatientsandhealthycontrols